Onychomycosis is a fungal infection treated orally for prolonged periods of treatment, caused primarily by Dermatophytes, Candida species and non-dermatophyte moulds (NDMs). The prevalence of specific aetiology may differ in dependence of environmental, geographic and demographic factors, and may affect management of the infection. The objective of this survey was to analyse epidemiologic parameters of onychomycosis in Israel. Data of a cohort of 27,093 patients were collected from six centres during a 2- and 10-year period. The diagnosis was based on microscopy of KOH/calcofluor mounts of nail scrapings and culture isolation. A positive result indicates isolation of a fungus in culture. Data were analysed for each centre and expressed as range for the whole cohort, using the spss v18 software. Analysis included three epidemiologic parameters: fungal aetiology in toe- and fingernails; association with gender; association with age group. Dermatophytes were the major causative agents and Trichophyton rubrum the most frequent isolate. Candida species were more frequent in women fingernails; frequency increased with age and C. parapsilosis the most frequent species. NDMs were isolated at low rate and Aspergillus terreus was the most frequent isolate. This is a first large cohort of onychomycosis patients from Israel analysed by defined epidemiological parameters.

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12287DOI Listing

Publication Analysis

Top Keywords

onychomycosis israel
8
candida species
8
epidemiologic parameters
8
frequent isolate
8
onychomycosis
4
israel epidemiological
4
epidemiological aspects
4
aspects onychomycosis
4
onychomycosis fungal
4
fungal infection
4

Similar Publications

We find the comment on the article titled "Diabetic Foot and Fungal Infections: Etiology and Management from a Dermatologic Perspective" informative and wish to thank the authors for their added insight on this complex topic [...

View Article and Find Full Text PDF
Article Synopsis
  • * Developing an mRNA-based vaccine for tinea cruris is proposed as a way to provide long-term immunity, reduce reliance on antifungal medications, and tackle issues like antifungal resistance.
  • * The study involves identifying potential protein candidates for the vaccine using reverse vaccinology, mapping immunogenic epitopes, and formulating a multitope mRNA vaccine with selected effective components to stimulate immunity.
View Article and Find Full Text PDF
Article Synopsis
  • Diabetes Mellitus (DM) leads to serious complications such as diabetic foot ulcers (DFU) and diabetic foot infections (DFI), increasing the risk of limb amputation and death.
  • * Superficial fungal infections like tinea pedis and onychomycosis heighten the risk of DFU and DFI in diabetic patients.
  • * The article emphasizes the importance of dermatologists in a multidisciplinary team to screen and manage these fungal infections, aiming to mitigate complications associated with diabetic foot health.
View Article and Find Full Text PDF

Tackling Inflammatory and Infectious Nail Disorders in Children.

Cutis

July 2024

Eden N. Axler and Dr. Lipner are from the Israel Englander Department of Dermatology, Weill Cornell Medicine, New York, New York. Dr. Bellet is from the Department of Dermatology and the Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.

Article Synopsis
  • * The review covers various inflammatory conditions like nail psoriasis and nail lichen planus, along with infectious issues such as onychomycosis and conditions related to hand, foot, and mouth disease.
  • * The goal is to enhance understanding of these disorders among dermatologists to improve diagnosis and treatment for affected children.
View Article and Find Full Text PDF

Introduction: Terbinafine is considered the gold standard for treating skin fungal infections and onychomycosis. However, recent reports suggest that dermatophytes are developing resistance to terbinafine and the other traditional antifungal agents, itraconazole and fluconazole. When there is resistance to terbinafine, itraconazole or fluconazole, or when these agents cannot used, for example, due to potential drug interactions with the patient's current medications, clinicians may need to consider off-label use of new generation azoles, such as voriconazole, posaconazole, fosravuconazole, or oteseconazole.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!